Atrys Health, S.A. (ATRY.MC)

EUR 2.88

(1.77%)

Operating Expenses Summary of Atrys Health, S.A.

Atrys Health, S.A.'s latest annual operating expenses in 2023 was 143.61 Million EUR , down -82.08% from previous year.
Atrys Health, S.A.'s latest quarterly operating expenses in 2024 Q2 was 2.08 Million EUR , down -89.59% from previous quarter.
Atrys Health, S.A. reported a annual operating expenses of 154.83 Million EUR in annual operating expenses 2022, up 36.67% from previous year.
Atrys Health, S.A. reported a annual operating expenses of 113.28 Million EUR in annual operating expenses 2021, up 404.48% from previous year.
Atrys Health, S.A. reported a quarterly operating expenses of 2.08 Million EUR for 2024 Q2, down -89.59% from previous quarter.
Atrys Health, S.A. reported a quarterly operating expenses of 17.29 Million EUR for 2023 Q1, down -11.69% from previous quarter.

Annual Operating Expenses Chart of Atrys Health, S.A. (2023 - 2012)

Historical Annual Operating Expenses of Atrys Health, S.A. (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	143.61 Million EUR	-82.08%
2022	154.83 Million EUR	36.67%
2021	113.28 Million EUR	404.48%
2020	22.45 Million EUR	104.0%
2019	11 Million EUR	78.51%
2018	6.16 Million EUR	14.89%
2017	5.36 Million EUR	18.2%
2016	4.54 Million EUR	746.38%
2015	536.48 Thousand EUR	200.29%
2014	-534.92 Thousand EUR	67.6%
2013	-1.65 Million EUR	7.02%
2012	-1.77 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	20.03 Million EUR	93.71%
2024 Q2	2.08 Million EUR	-89.59%
2023 Q1	17.29 Million EUR	-11.69%
2023 Q4	10.34 Million EUR	-13.22%
2023 FY	27.74 Million EUR	-82.08%
2023 Q3	11.91 Million EUR	-41.28%
2023 Q2	20.29 Million EUR	17.37%
2022 Q2	20.58 Million EUR	32.93%
2022 FY	154.83 Million EUR	36.67%
2022 Q3	25.48 Million EUR	23.81%
2022 Q1	15.48 Million EUR	-40.69%
2022 Q4	19.58 Million EUR	-23.15%
2021 Q4	26.1 Million EUR	49.62%
2021 Q2	9.12 Million EUR	21.73%
2021 Q3	17.44 Million EUR	91.27%
2021 FY	113.28 Million EUR	404.48%
2021 Q1	7.49 Million EUR	19.55%
2020 FY	22.45 Million EUR	104.0%
2020 Q2	1.55 Million EUR	-0.0%
2020 Q1	1.55 Million EUR	-41.88%
2020 Q3	6.26 Million EUR	303.28%
2020 Q4	6.26 Million EUR	0.0%
2019 Q4	2.67 Million EUR	44.82%
2019 Q2	1.46 Million EUR	45.36%
2019 Q3	1.84 Million EUR	25.75%
2019 Q1	1.01 Million EUR	-17.2%
2019 FY	11 Million EUR	78.51%
2018 Q1	854.45 Thousand EUR	3.6%
2018 FY	6.16 Million EUR	14.89%
2018 Q4	1.21 Million EUR	47.97%
2018 Q3	824.46 Thousand EUR	-26.46%
2018 Q2	1.12 Million EUR	31.2%
2017 Q4	824.73 Thousand EUR	0.0%
2017 FY	5.36 Million EUR	18.2%
2017 Q2	692.73 Thousand EUR	-0.0%
2017 Q1	692.73 Thousand EUR	9.42%
2017 Q3	824.73 Thousand EUR	19.05%
2016 Q1	312.6 Thousand EUR	0.0%
2016 Q2	312.6 Thousand EUR	0.0%
2016 FY	4.54 Million EUR	746.38%
2016 Q4	633.08 Thousand EUR	0.0%
2016 Q3	633.08 Thousand EUR	102.52%
2015 FY	536.48 Thousand EUR	200.29%
2014 FY	-534.92 Thousand EUR	67.6%
2013 FY	-1.65 Million EUR	7.02%
2012 FY	-1.77 Million EUR	0.0%

Peer Operating Expenses Comparison of Atrys Health, S.A.

Name	Operating Expenses	Operating Expenses Difference
Biotechnologies Assets SA	840.45 Thousand EUR	-16987.751%
Oryzon Genomics S.A.	18.49 Million EUR	-676.413%
Pharma Mar, S.A.	152.36 Million EUR	5.745%
Laboratorios Farmaceuticos Rovi, S.A.	263.09 Million EUR	45.413%